Stock Analysis·← Pickers

GCTK

GlucoTrack, Inc.

GlucoTrack, Inc. (GCTK) is currently in a range/mixed trend, above the 50-day MA but below the 200-day MA. RSI is at 63.1, with 1/3 trend checks passing.

Price
$0.53
2026-07-16
Trend score
1/3
Range / Mixed
RSI (14)
63.1
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

GCTK with MA50 and MA200

10.598.025.452.880.3107/3110/2401/2204/1707/15
GCTK2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$0.52+1.80% vs price
MA200
$2.86-81.50% vs price
RSI (14)
63.1Neutral zone
MACD Signal
BullishMomentum above signal
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for GCTK

GlucoTrack, Inc. (GCTK) currently looks more uncertain than directional, with a fairly mixed technical picture. The latest available price is $0.53, and 1 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 1.8% and below the 200-day moving average by 81.5%.

Momentum and stretch context

GCTK currently has an RSI reading of 63.1, which leans mildly positive without looking too stretched. In other words, momentum is supportive, but not yet extreme enough to dominate the entire chart read.

What traders may watch next

This page is designed to help you quickly understand what the GCTK chart looks like before opening the full dashboard. The aim is not to tell you what to buy or sell, but to make it easier to judge whether the stock is trending cleanly, becoming stretched, or simply moving in a more awkward range.

Company profile

About GlucoTrack, Inc.

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul V. Goode
Employees
15
Market cap
$300.2K
Beta
0.76
52-week range
$0.29 – $14.14
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
25 Apr 2013
ISIN
US45824Q8042
CUSIP
45824Q804
Company profile data from Financial Modeling Prep. GCTK listed on NASDAQ.
Share dilution

GCTK shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
1.6M
Since Jun 2019
+2274.1%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. GCTK28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about GCTK

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.